CVS

05.01.2023 • News

Novartis to Pay $245 Million in ’Pay for Delay’ Settlement

Novartis has agreed to pay a total of $245 million to settle lawsuits filed by direct purchasers, indirect purchasers and retailers accusing it of colluding with Par Pharmaceutical to delay the launch of a generic version of its Exforge (valsartan/amlodipine) hypertension drug.

12.06.2020 • Topics • Logistics

Pharmaceutical Logistics in North America

02.07.2013 • News

Celesio Eyed By 2 U.S. Drug Distributors

Top-Feature

greenCHEM

Future Prospects in Green Chemistry

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Camelot Management Consultants AG

CVS